Dynavax Technologies
DVAX
DVAX was delisted on the 9th of February, 2026.
230 hedge funds and large institutions have $1.23B invested in Dynavax Technologies in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 85 increasing their positions, 78 reducing their positions, and 21 closing their positions.
102% more call options, than puts
Call options by funds: $10.7M | Put options by funds: $5.31M
9% more repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 78
3% more capital invested
Capital invested by funds: $1.2B → $1.23B (+$33.1M)
0.68% more ownership
Funds ownership: 91.52% → 92.2% (+0.68%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
10% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 21
3% less funds holding
Funds holding: 236 → 230 (-6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$27M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$12.1M |
| 3 |
Morgan Stanley
New York
|
+$7.3M |
| 4 |
BlackRock
New York
|
+$6.75M |
| 5 |
Renaissance Technologies
New York
|
+$6.34M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
-$17.4M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$15.4M |
| 3 |
Millennium Management
New York
|
-$9.34M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$6.25M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$5.69M |
DVAX Hedge Fund Activity: Q4 2022 in Review
230 of the 6,223 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q4 2022, worth a combined $1.23B — up 2.8% from $1.2B a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of DVAX and 19 opened new positions — a net loss of 2 holders — while 78 trimmed existing stakes and 85 added.
The largest buyer was Deep Track Capital, opening a new position worth an estimated $27M. The largest seller was Bain Capital Life Sciences Investors, cutting an estimated $17.4M.
- 230 institutional investors held Dynavax Technologies (DVAX) as of Q4 2022, down from 236 in Q3 2022.
- Funds reported $1.23B of Dynavax Technologies stock for Q4 2022, up 2.8% quarter-over-quarter.
- 19 funds opened new Dynavax Technologies positions in Q4 2022 and 21 closed out, a net change of -2 holders.
- The largest Dynavax Technologies buyer in Q4 2022 was Deep Track Capital, an estimated $27M added.
- The largest Dynavax Technologies seller in Q4 2022 was Bain Capital Life Sciences Investors, an estimated $17.4M sold.
Based on aggregated 13F filings for Q4 2022.